"“I’ve seen first-hand how devastating depression can be for individuals, families, and communities; often, current options are ineffective. I’m a passionate believer in the potential of psychedelic therapies to alleviate suffering and provide the catalyst for transformative change, I’m excited to be part of a team which shares this vision.”"

Daniel Sutcliffe

Market Access Manager

Focuses on market access, market strategy, and value communication.

Daniel is a pharmacist with experience spanning public, private, and non-profit organisations. Before joining COMPASS, Daniel worked at Parexel Access Consulting, where he advised global pharmaceutical companies on market access strategy and value communication. Daniel has a diverse range of experience assisting in the commercialisation of pharmaceutical products, ranging from cell/gene therapies for ultra-orphan indications, to novel psychoactive compounds for treatment-resistant depression, opioid addiction, and suicidality.

Before Parexel, Daniel worked for the Royal Pharmaceutical Society, where he managed numerous advocates, projects, and workstreams. Prior to this, Daniel worked within the NHS as a Pharmacist. Daniel holds a master’s degree in Pharmacy from the University of Kent.

"“I’ve seen first-hand how devastating depression can be for individuals, families, and communities; often, current options are ineffective. I’m a passionate believer in the potential of psychedelic therapies to alleviate suffering and provide the catalyst for transformative change, I’m excited to be part of a team which shares this vision.”"